This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $376,355 to support research on the role of microglial insulin-like growth factor 1 (IGF1) in epileptogenesis. The award, which runs from May 15, 2025 to April 30, 2030, aims to characterize how microglial mTOR signaling and IGF1 expression propagate to surrounding cells, evaluate the impact of microglial IGF1 on central nervous system homeostasis, and determine if IGF1 plays a role in the pathological process that transforms a normal brain into an epileptic brain. The research will be conducted by Albany Medical College, a private, non-profit medical school and academic medical center in Albany, New York.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $376.4k | 5/14/25 |